Global Obesity Pipeline Surges Past 80 Pharma Companies in Active Clinical Trials
Over 80 pharmaceutical companies are running clinical trials in obesity. Boehringer Ingelheim is advancing survodutide into three global Phase III trials, positioning it as a key next-generation GLP-1 competitor.